Treatment options, selection, and satisfaction among african american and white men with prostate carcinoma in north carolina

Demark‐Wahnefried, Wendy; Schildkraut, Joellen M.; Iselin, Christophe; Conlisk, Elizabeth; Kavee, Andrew L.; Aldrich, Tim E.; Lengerich, Eugene J.; Walther, Philip; Paulson, David F.

doi:10.1002/(sici)1097-0142(19980715)83:2<320::aid-cncr16>3.0.co;2-v

Cited by 47 publications

(37 citation statements)

References 21 publications

(31 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, an interview study of black and white men in North Carolina failed to find an association between treatment and race. 19 Conversely, other studies have found lower rates of aggressive treatment among black men than among white men. 8,20 The latter studies included men covered by various health insurance systems, with the results not adjusted for insurance status.…”

Section: Discussionmentioning

confidence: 94%

Initial treatment for prostate carcinoma in relation to comorbidity and symptoms

Hall¹,

Satariano²,

Thompson³

et al. 2002

Cancer

View full text Add to dashboard Cite

BACKGROUNDEvidence suggests the type of treatment received for prostate carcinoma is associated with comorbidity, but little information is available on associations with specific comorbid disease or symptoms. The authors examined the relations between treatment and comorbidity, specific comorbid disease, and symptoms.METHODSMedical records were abstracted for 1054 male members of the Kaiser Permanente medical care program diagnosed with prostate carcinoma from 1975 to 1987. Information was obtained on demographic characteristics, comorbid conditions, symptoms, tumor stage and grade, and treatment. Logistic regression was used to determine the significant predictors of treatment (radiation vs. nonaggressive treatment and surgery vs. nonaggressive treatment).RESULTSCompared to nonaggressive treatment, radiation treatment was less likely among men who had prior cancer (adjusted odds ratio [OR] 0.29, 95% confidence interval [CI] 0.09–0.90) or cerebrovascular disease (OR 0.33, 95% CI 0.13–0.83). There was a significant interaction between race and myocardial infarction (P = 0.02). Surgery, compared to nonaggressive treatment, was less common among men with a prior cancer (OR 0.21, 95% CI 0.07–0.63) or congestive heart failure (OR 0.29, 95% CI 0.09–0.90). Significant interactions were observed between race and myocardial infarction (P = 0.01), diabetes and dysuria or hematuria (P = 0.02), and para‐ or hemiplegia and urinary frequency or nocturia (P = 0.01).CONCLUSIONSSpecific symptoms and comorbidity appear to influence treatment for prostate carcinoma. More research is needed on treatment differences by race. Cancer 2002;95:2308–15. Published 2002 by the American Cancer Society.DOI 10.1002/cncr.10926

show abstract

Section: Discussionmentioning

confidence: 94%

Initial treatment for prostate carcinoma in relation to comorbidity and symptoms

Hall¹,

Satariano²,

Thompson³

et al. 2002

Cancer

View full text Add to dashboard Cite

show abstract

“…These included 16 survey studies, [3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18] 16 studies aimed at designing and exploring decision aids, 19 -34 16 focus group studies regarding treatment decision making, [35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50] 10 studies examining shared decision making between patients and physicians, [51][52][53][54][55][56][57][58][59][60] 6 studies exploring health state preferences associated with treatment decision making, [61][62][63][64][65][66] and 5 review articles related to treatment decision making.…”

Section: Resultsmentioning

confidence: 99%

“…5 Fear of side effects was also stated by only 3% of men in a study in North Carolina, in which the majority of patients were black. 8 Srirangam et al 45 reported that although 55% of spouses reported that side effects were important, only 6% indicated that side effects were deciding factors. One study comparing surgery and brachytherapy reported that 25% of patients chose between these 2 options based on the side effect profile.…”

Section: Treatment-related Side Effects and Their Impact On Healthrelmentioning

confidence: 99%

“…In studies that asked men to report the major influencing factor in their decision, the physician was identified by 57% of patients in 1 study, 8 by 65% of patients in a second study, 9 and by 70% of patients in a third study. 14 Holmboe and Concato 10 noted that 30% of men explicitly mentioned physician recommendation as being important to their decision.…”

Section: Framing and Interpreting Influences In Prostate Cancer Decismentioning

confidence: 99%

See 1 more Smart Citation

Why do men choose one treatment over another?

Zeliadt

Ramsey

Penson

et al. 2006

Cancer

228

100

View full text Add to dashboard Cite

“…AA men are nearly 60 % more likely to be diagnosed with PCa and more than twice as likely to die from it compared to white men. 11 Physicians are less likely to discuss treatments with AA men compared to white men, 12 and cultural barriers may prevent AA men from seeking emotional support regarding their PCa. 13 This suboptimal communication can lead to increased decisional conflict, increased anxiety, and poorer quality of life (QOL).…”

Section: Introductionmentioning

confidence: 99%

Interventions to Improve Decision Making and Reduce Racial and Ethnic Disparities in the Management of Prostate Cancer: A Systematic Review

2012

View full text Add to dashboard Cite

OBJECTIVES: Ethnic minorities are disproportionately impacted by prostate cancer (PCa) and are at risk for not receiving informed decision making (IDM). We conducted a systematic literature review on interventions to improve: (1) IDM about PCa in screeningeligible minority men, and (2) quality of life (QOL) in minority PCa survivors. DATA SOURCES: MeSH headings for PCa, ethnic minorities, and interventions were searched in MED-LINE, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, CINAHL, and PsycINFO. SUBJECT ELIGIBILITY CRITERIA: We identified U.S.-based, English-language articles (1985-2010) on interventions to improve PCa IDM and QOL that included 50 % or more minority patients or analyses stratified by race/ethnicity. STUDY APPRAISAL AND SYNTHESIS METHODS:Articles (n=19) were evaluated and scored for quality using a Downs and Black (DB) system. Interventions were organized by those enhancing 1) IDM about PCa screening and 2) improving QOL and symptom among PCa survivors. Outcomes were reported by intervention type (educational seminar, printed material, telephonebased, video and web-based). RESULTS: Fourteen studies evaluated interventions for enhancing IDM about PCa screening and five evaluated programs to improve outcomes for PCa survivors. Knowledge scores were statistically significantly increased in 12 of 13 screening studies that measured knowledge, with ranges of effect varying across intervention types: educational programs (13 %-48 % increase), print (11 %-18 %), videotape/DVD (16 %), and web-based (7 %-20 %). In the final screening study, an intervention to improve decision-making about screening increased decisional self-efficacy by 9 %. Five cognitive-behavioral interventions improved QOL among minority men being treated for localized PCa through enhancing problem solving and coping skills. LIMITATIONS: Weak study designs, small sample sizes, selection biases, and variation in follow-up intervals across studies. CONCLUSIONS: Educational programs were the most effective intervention for improving knowledge among screening-eligible minority men. Cognitive behavioral strategies improved QOL for minority men treated for localized PCa.

show abstract

Treatment options, selection, and satisfaction among african american and white men with prostate carcinoma in north carolina

Cited by 47 publications

References 21 publications

Initial treatment for prostate carcinoma in relation to comorbidity and symptoms

Initial treatment for prostate carcinoma in relation to comorbidity and symptoms

Why do men choose one treatment over another?

Interventions to Improve Decision Making and Reduce Racial and Ethnic Disparities in the Management of Prostate Cancer: A Systematic Review

Contact Info

Product

Resources

About